Kingstone Cos., Inc. (KINS) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1156598,
    "name": "Kingstone Cos., Inc.",
    "stock_name": "Kingstone Cos., Inc.",
    "full_name": "Kingstone Cos., Inc.",
    "name_url": "stocks-analysis/kingstone-cos-inc",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "15.13",
    "chg": 0.31,
    "chgp": "2.09%",
    "dir": 1,
    "prev_price": "14.82",
    "mcapval": "208.58",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Capital Markets",
    "ind_code": 4880,
    "indexname": "S&P 500",
    "isin": "US4967191051",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "230.48 k",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/kingstone-cos-inc-1156598-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Is Kingstone Cos., Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-kingstone-cos-inc-overvalued-or-undervalued-3728362",
        "imagepath": "",
        "date": "2025-11-25 11:15:03",
        "description": "As of 21 November 2025, the valuation grade for Kingstone Cos., Inc. has moved from attractive to fair. The company appears to be fairly valued based on its current metrics, with a P/E ratio of 11, a Price to Book Value of 2.87, and an EV to Sales ratio of 1.25. In comparison to peers, Crawford & Co. has a higher P/E of 17.88, while GoHealth, Inc. shows a significantly lower P/E of 2.12, indicating that Kingstone is positioned between these two companies in terms of valuation.\n\nWhile Kingstone has experienced a remarkable 3-year return of 1520.70%, it has underperformed relative to the S&P 500 over the past year, with a return of -2.64% compared to the index's 11.00%. This suggests that although the company has had strong historical performance, its current valuation does not reflect the same growth potential moving forward...."
      },
      {
        "title": "Is Kingstone Cos., Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-kingstone-cos-inc-overvalued-or-undervalued-3723355",
        "imagepath": "",
        "date": "2025-11-23 11:10:45",
        "description": "As of 21 November 2025, the valuation grade for Kingstone Cos., Inc. has moved from attractive to fair, indicating a shift in its perceived value. The company appears to be fairly valued at this time. Key valuation ratios include a P/E ratio of 11, a Price to Book Value of 2.87, and an EV to Sales ratio of 1.25. In comparison, peer Crawford & Co. has a higher P/E ratio of 17.88, while GoHealth, Inc. shows a significantly lower P/E of 2.12, highlighting the varying valuations within the industry.\n\nDespite the recent downgrade in valuation, Kingstone's stock has outperformed the S&P 500 over the last three years, with a remarkable return of 1483.87% compared to the S&P 500's 67.17%. However, the year-to-date performance shows a decline of 3.03% against the S&P 500's gain of 12.26%, suggesting that while the long-term outlook has been strong, recent performance may warrant caution...."
      },
      {
        "title": "Is Kingstone Cos., Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-kingstone-cos-inc-overvalued-or-undervalued-3711424",
        "imagepath": "",
        "date": "2025-11-18 11:13:53",
        "description": "As of 14 November 2025, the valuation grade for Kingstone Cos., Inc. has moved from attractive to fair. The company appears to be fairly valued based on its current metrics, with a P/E ratio of 11, a price to book value of 2.87, and an EV to EBITDA of 76.30. In comparison to peers, Crawford & Co. has a higher P/E ratio of 17.88, while GoHealth, Inc. shows a significantly lower P/E of 2.12, indicating that Kingstone is positioned in the middle of its peer group.\n\nDespite the fair valuation, Kingstone's recent performance against the S&P 500 is not available for analysis, which limits the ability to draw conclusions about its relative market performance. Overall, the current valuation suggests that Kingstone Cos., Inc. is neither undervalued nor overvalued, aligning closely with its peers in the capital markets industry...."
      },
      {
        "title": "Is Kingstone Cos., Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-kingstone-cos-inc-overvalued-or-undervalued-3706948",
        "imagepath": "",
        "date": "2025-11-17 11:08:03",
        "description": "As of 14 November 2025, the valuation grade for Kingstone Cos., Inc. has moved from attractive to fair, indicating a shift in its perceived value. The company appears to be overvalued based on its current metrics, particularly with a P/E ratio of 11, a Price to Book Value of 2.87, and an EV to EBITDA of 76.30, which are significantly higher than its peers like GoHealth, Inc. with a P/E of 2.12 and an EV to EBITDA of 0.42. \n\nIn comparison to the S&P 500, Kingstone has shown a strong performance over the 3-year period with a return of 768.28%, but it has underperformed year-to-date with a return of -5.40% compared to the S&P 500's 14.49%. Overall, the combination of the valuation metrics and peer comparisons suggests that Kingstone Cos., Inc. is currently overvalued...."
      },
      {
        "title": "Is Kingstone Cos., Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-kingstone-cos-inc-overvalued-or-undervalued-3705588",
        "imagepath": "",
        "date": "2025-11-16 11:04:52",
        "description": "As of 14 November 2025, the valuation grade for Kingstone Cos., Inc. has moved from attractive to fair. The company appears to be overvalued given its current metrics, including a P/E ratio of 11, a Price to Book Value of 2.87, and an EV to EBITDA of 76.30. In comparison, peers such as Crawford & Co. have a P/E of 17.88 and an EV to EBITDA of 4.11, indicating that Kingstone is trading at a premium relative to its industry.\n\nDespite a strong one-year return of 33.06% compared to the S&P 500's 13.19%, the company's year-to-date performance of -5.40% against the S&P's 14.49% suggests a struggle to maintain momentum. Overall, the combination of valuation ratios and peer comparisons supports the conclusion that Kingstone Cos., Inc. is currently overvalued...."
      },
      {
        "title": "Kingstone Cos., Inc. Experiences Revision in Its Stock Evaluation Amid Strong Market Performance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kingstone-cos-inc-upgraded-from-fair-to-attractive-valuation-grade-3686203",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/KingstoneCosInc_valuationdot_3686203.png",
        "date": "2025-11-10 15:43:04",
        "description": "Kingstone Cos., Inc. has adjusted its valuation, with a P/E ratio of 11 and a price-to-book value of 2.87. The company boasts a strong return on equity of 25.77%. Its stock performance has outpaced the S&P 500, achieving a one-year return of 34.66% and a three-year return of 620.39%."
      },
      {
        "title": "Is Kingstone Cos., Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-kingstone-cos-inc-overvalued-or-undervalued-3685052",
        "imagepath": "",
        "date": "2025-11-10 11:14:49",
        "description": "As of 7 November 2025, the valuation grade for Kingstone Cos., Inc. moved from fair to attractive, indicating a more favorable assessment of its value. The company appears to be undervalued, particularly when considering its P/E ratio of 11, which is significantly lower than its peer Crawford & Co. at 17.88, and its EV to EBITDA ratio of 76.30, which is higher than the industry average. Additionally, the price to book value stands at 2.87, suggesting potential for growth relative to its book value.\n\nIn comparison to its peers, Kingstone Cos., Inc. shows a more attractive valuation with a P/E of 7.47 for its closest competitor, GoHealth, Inc., which has a P/E of 2.12, indicating that Kingstone is positioned better in terms of earnings potential. While the stock's return data is not available for a direct comparison with the S&P 500, the overall valuation metrics suggest that Kingstone Cos., Inc. is well-posi..."
      },
      {
        "title": "Is Kingstone Cos., Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-kingstone-cos-inc-overvalued-or-undervalued-3683155",
        "imagepath": "",
        "date": "2025-11-09 11:08:25",
        "description": "As of 7 November 2025, the valuation grade for Kingstone Cos., Inc. has moved from fair to attractive, indicating a more favorable assessment of its market position. The company appears undervalued, particularly when considering its P/E ratio of 11, which is significantly lower than the peer average of 17.88 for Crawford & Co., and its EV to Sales ratio of 1.25, which suggests potential for growth relative to its sales. Additionally, Kingstone's ROE of 25.77% highlights its strong profitability compared to peers.\n\nIn terms of peer comparison, Kingstone's P/E ratio of 11 is notably lower than Crawford & Co.'s 17.88, while its EV to EBITDA of 76.30 is much higher than GoHealth, Inc.'s 0.4180, indicating a disparity in valuation metrics across the sector. Recent stock performance shows that Kingstone outperformed the S&P 500 over the past year with a return of 34.66% compared to the index's 12.65%, reinforcing..."
      },
      {
        "title": "Is Kingstone Cos., Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-kingstone-cos-inc-technically-bullish-or-bearish-3546863",
        "imagepath": "",
        "date": "2025-09-20 19:41:58",
        "description": "As of 11 September 2025, the technical trend for Kingstone Cos., Inc. has changed from bearish to mildly bearish. The current stance is mildly bearish, driven by a bearish MACD on the weekly timeframe and a bearish signal from the daily moving averages. The Bollinger Bands show a bullish signal on the monthly timeframe, which contrasts with the overall bearish indicators. The stock has underperformed the S&P 500 in the short term, with a year-to-date return of -9.61% compared to the S&P 500's 12.22%, but it has significantly outperformed over the longer term, with a 3-year return of 307.42% versus 70.41% for the S&P 500...."
      }
    ],
    "total": 15,
    "sid": "1156598",
    "stock_news_url": "https://www.marketsmojo.com/news/kingstone-cos-inc-1156598"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Is Kingstone Cos., Inc. overvalued or undervalued?

2025-11-25 11:15:03

As of 21 November 2025, the valuation grade for Kingstone Cos., Inc. has moved from attractive to fair. The company appears to be fairly valued based on its current metrics, with a P/E ratio of 11, a Price to Book Value of 2.87, and an EV to Sales ratio of 1.25. In comparison to peers, Crawford & Co. has a higher P/E of 17.88, while GoHealth, Inc. shows a significantly lower P/E of 2.12, indicating that Kingstone is positioned between these two companies in terms of valuation. While Kingstone has experienced a remarkable 3-year return of 1520.70%, it has underperformed relative to the S&P 500 over the past year, with a return of -2.64% compared to the index's 11.00%. This suggests that although the company has had strong historical performance, its current valuation does not reflect the same growth potential moving forward....

Is Kingstone Cos., Inc. overvalued or undervalued?

2025-11-23 11:10:45

As of 21 November 2025, the valuation grade for Kingstone Cos., Inc. has moved from attractive to fair, indicating a shift in its perceived value. The company appears to be fairly valued at this time. Key valuation ratios include a P/E ratio of 11, a Price to Book Value of 2.87, and an EV to Sales ratio of 1.25. In comparison, peer Crawford & Co. has a higher P/E ratio of 17.88, while GoHealth, Inc. shows a significantly lower P/E of 2.12, highlighting the varying valuations within the industry. Despite the recent downgrade in valuation, Kingstone's stock has outperformed the S&P 500 over the last three years, with a remarkable return of 1483.87% compared to the S&P 500's 67.17%. However, the year-to-date performance shows a decline of 3.03% against the S&P 500's gain of 12.26%, suggesting that while the long-term outlook has been strong, recent performance may warrant caution....

Is Kingstone Cos., Inc. overvalued or undervalued?

2025-11-18 11:13:53

As of 14 November 2025, the valuation grade for Kingstone Cos., Inc. has moved from attractive to fair. The company appears to be fairly valued based on its current metrics, with a P/E ratio of 11, a price to book value of 2.87, and an EV to EBITDA of 76.30. In comparison to peers, Crawford & Co. has a higher P/E ratio of 17.88, while GoHealth, Inc. shows a significantly lower P/E of 2.12, indicating that Kingstone is positioned in the middle of its peer group. Despite the fair valuation, Kingstone's recent performance against the S&P 500 is not available for analysis, which limits the ability to draw conclusions about its relative market performance. Overall, the current valuation suggests that Kingstone Cos., Inc. is neither undervalued nor overvalued, aligning closely with its peers in the capital markets industry....

Is Kingstone Cos., Inc. overvalued or undervalued?

2025-11-17 11:08:03

As of 14 November 2025, the valuation grade for Kingstone Cos., Inc. has moved from attractive to fair, indicating a shift in its perceived value. The company appears to be overvalued based on its current metrics, particularly with a P/E ratio of 11, a Price to Book Value of 2.87, and an EV to EBITDA of 76.30, which are significantly higher than its peers like GoHealth, Inc. with a P/E of 2.12 and an EV to EBITDA of 0.42. In comparison to the S&P 500, Kingstone has shown a strong performance over the 3-year period with a return of 768.28%, but it has underperformed year-to-date with a return of -5.40% compared to the S&P 500's 14.49%. Overall, the combination of the valuation metrics and peer comparisons suggests that Kingstone Cos., Inc. is currently overvalued....

Is Kingstone Cos., Inc. overvalued or undervalued?

2025-11-16 11:04:52

As of 14 November 2025, the valuation grade for Kingstone Cos., Inc. has moved from attractive to fair. The company appears to be overvalued given its current metrics, including a P/E ratio of 11, a Price to Book Value of 2.87, and an EV to EBITDA of 76.30. In comparison, peers such as Crawford & Co. have a P/E of 17.88 and an EV to EBITDA of 4.11, indicating that Kingstone is trading at a premium relative to its industry. Despite a strong one-year return of 33.06% compared to the S&P 500's 13.19%, the company's year-to-date performance of -5.40% against the S&P's 14.49% suggests a struggle to maintain momentum. Overall, the combination of valuation ratios and peer comparisons supports the conclusion that Kingstone Cos., Inc. is currently overvalued....

Kingstone Cos., Inc. Experiences Revision in Its Stock Evaluation Amid Strong Market Performance

2025-11-10 15:43:04

Kingstone Cos., Inc. has adjusted its valuation, with a P/E ratio of 11 and a price-to-book value of 2.87. The company boasts a strong return on equity of 25.77%. Its stock performance has outpaced the S&P 500, achieving a one-year return of 34.66% and a three-year return of 620.39%.

Is Kingstone Cos., Inc. overvalued or undervalued?

2025-11-10 11:14:49

As of 7 November 2025, the valuation grade for Kingstone Cos., Inc. moved from fair to attractive, indicating a more favorable assessment of its value. The company appears to be undervalued, particularly when considering its P/E ratio of 11, which is significantly lower than its peer Crawford & Co. at 17.88, and its EV to EBITDA ratio of 76.30, which is higher than the industry average. Additionally, the price to book value stands at 2.87, suggesting potential for growth relative to its book value. In comparison to its peers, Kingstone Cos., Inc. shows a more attractive valuation with a P/E of 7.47 for its closest competitor, GoHealth, Inc., which has a P/E of 2.12, indicating that Kingstone is positioned better in terms of earnings potential. While the stock's return data is not available for a direct comparison with the S&P 500, the overall valuation metrics suggest that Kingstone Cos., Inc. is well-posi...

Is Kingstone Cos., Inc. overvalued or undervalued?

2025-11-09 11:08:25

As of 7 November 2025, the valuation grade for Kingstone Cos., Inc. has moved from fair to attractive, indicating a more favorable assessment of its market position. The company appears undervalued, particularly when considering its P/E ratio of 11, which is significantly lower than the peer average of 17.88 for Crawford & Co., and its EV to Sales ratio of 1.25, which suggests potential for growth relative to its sales. Additionally, Kingstone's ROE of 25.77% highlights its strong profitability compared to peers. In terms of peer comparison, Kingstone's P/E ratio of 11 is notably lower than Crawford & Co.'s 17.88, while its EV to EBITDA of 76.30 is much higher than GoHealth, Inc.'s 0.4180, indicating a disparity in valuation metrics across the sector. Recent stock performance shows that Kingstone outperformed the S&P 500 over the past year with a return of 34.66% compared to the index's 12.65%, reinforcing...

Is Kingstone Cos., Inc. technically bullish or bearish?

2025-09-20 19:41:58

As of 11 September 2025, the technical trend for Kingstone Cos., Inc. has changed from bearish to mildly bearish. The current stance is mildly bearish, driven by a bearish MACD on the weekly timeframe and a bearish signal from the daily moving averages. The Bollinger Bands show a bullish signal on the monthly timeframe, which contrasts with the overall bearish indicators. The stock has underperformed the S&P 500 in the short term, with a year-to-date return of -9.61% compared to the S&P 500's 12.22%, but it has significantly outperformed over the longer term, with a 3-year return of 307.42% versus 70.41% for the S&P 500....

View All News